bioRxiv Science⌕ Search

Biology subjects

Wang, M. Y.

Publications and source records attributed to Wang, M. Y..

8 recordsLinked to original sources

Attrition Rates in Mindfulness-Based Interventions for Chronic Pain: A Meta-Analysis

ObjectiveMindfulness-based interventions (MBIs) show promise in managing chronic pain but often require substantial time commitments, leading to high attrition rates and concerns about acceptability. This meta-analysis evaluated attrition rates in MBIs for chronic pain and explored factors contributing to participant withdrawal. MethodsFollowing PRISMA guidelines, 44 studies (45 intervention conditions) were analysed. Data on attrition rates, program characteristics (e.g., delivery method, group vs. individual therapy, session duration), and participant demographics were extracted. Meta-analyses of proportions assessed moderators influencing attrition rates. ResultsThe overall weighted mean attrition rate was 30.1% (95% CI: 24.5% to 37.3%) with substantial heterogeneity (I{superscript 2} = 89.0%). Stricter completion thresholds (defined as the minimum number of sessions required to be considered a programme completer) were associated with higher attrition (p < 0.001, R{superscript 2} = 28.1%), ranging from an 18% attrition rate for low thresholds (completion of [&ge;]3 sessions required to be defined as a completer) to a 49.7% attrition rate for high thresholds ([&ge;]6 sessions). Online delivery showed higher attrition rates (51.0%) compared to in-person delivery (25.6%, p = 0.002, R{superscript 2} = 17.1%). Individually delivered MBIs were also linked to higher attrition compared to group formats ({beta} = 0.216, p = 0.039, R{superscript 2} = 5.5%). ConclusionsAttrition rates for MBIs in chronic pain management vary widely. Higher attrition is associated with stricter completion criteria, online delivery, and individual formats. These findings highlight the need to optimise MBI programme structure to reduce attrition in MBIs for chronic pain management.

pathology↗

Antigen-specific T cell immunotherapy by in vivo mRNA delivery

Immunotherapy has shown promise for treating patients with autoimmune diseases or cancer, yet treatment is associated with adverse effects associated with global activation or suppression of T cell immunity. Here, we developed antigen-presenting nanoparticles (APNs) to selectively engineer disease antigen (Ag)-specific T cells by in vivo mRNA delivery. APNs consist of a lipid nanoparticle core functionalized with peptide-major histocompatibility complexes (pMHCs), facilitating antigen-specific T cell transfection through cognate T cell receptor-mediated endocytosis. In mouse models of type 1 diabetes and multiple myeloma, APNs selectively deplete autoreactive T cells leading to durable control of glycemia, and engineer virus-specific T cells with anti-cancer chimeric antigen receptors (CARs), achieving comparable therapeutic outcome as virally transduced ex vivo CAR. Overall, our work supports the use of APNs to engineer disease-relevant T cells in vivo as Ag-specific immunotherapy for autoimmune disorders and cancer.

bioengineering↗

Structural transitions in kinesin minus-end directed microtubule motility

Kinesin motor proteins hydrolyze ATP to produce force for spindle assembly and vesicle transport, performing essential functions in cell division and motility, but the structural changes required for force generation are uncertain. We now report high-resolution structures showing new transitions in the kinesin mechanochemical cycle, including power stroke fluctuations upon ATP binding and a post-hydrolysis state with bound ADP + free phosphate. We find that rate-limiting ADP release occurs upon microtubule binding, accompanied by central {beta}-sheet twisting, which triggers the power stroke - stalk rotation and neck mimic docking - upon ATP binding. Microtubule release occurs with {beta}-strand-to-loop transitions, implying that {beta}-strand refolding induces Pi release and the recovery stroke. The strained {beta}-sheet during the power stroke and strand-to-loop transitions identify the {beta}-sheet as the long-sought motor spring. TeaserStalk rotation, {beta}-sheet twisting and refolding, and neck mimic docking drive the reversed working stroke of kinesin-14 INTRODUCTIONKinesin family proteins couple ATP hydrolysis to microtubule binding, generating force to produce steps or displacements along microtubules. The mechanism by which kinesins and other cytoskeletal motor proteins produce force is not fully understood. A current hypothesis is that the motors contain a spring-like or elastic element that creates strain under load during nucleotide binding or release, followed by a strain-relieving conformational change that produces force and a working stroke of the motor. The spring has not yet been identified for any motor. The power stroke differs for different motors - it consists of neck linker docking for plus-end directed kinesin-1 or a swing of the helical stalk for minus-end directed kinesin-14. RATIONALEDespite considerable research, the molecular dynamics of the kinesin-14 power stroke are still obscure, impeded by the weak microtubule binding of the motor. We overcame the weak binding by introducing a point mutation into the motor that results in faster ATP hydrolysis than wild type and tighter microtubule binding, which enabled us to resolve the motor mode of action. We now present high-resolution cryo-electron microscopy (cryo-EM) and x-ray structures of key mechanochemical states across the full force-producing cycle of a kinesin dimeric motor. RESULTSThe new structures represent five different nucleotide states - two pre-power stroke states, a fluctuating power stroke, and two post-power stroke states. The structures are both microtubule-attached and unattached. They show the motor trapped in previously unreported transition states and reveal new conformational changes involved in energy transduction. The new transition states include a transient state in which the power stroke fluctuates during ATP binding and a new state of a kinesin motor bound to ADP and free Pi prior to phosphate release. The conformational changes include the folding of the kinesin-14 neck mimic into a structure resembling the docked kinesin-1 neck linker, accompanying the power stroke, and previously unreported {beta}-strand-to-loop transitions with stored free energy that potentially induce Pi release and drive the recovery stroke. We interpret the new structures in the context of the hypothesis that the central {beta}-sheet undergoes distortional changes during the mechanochemical cycle that store and release free energy, functioning as the elusive spring of the motors. CONCLUSIONThe new structures show that force is produced by coupled movements of the helical stalk, central {beta}-sheet, and neck mimic, and uncover structural changes during the power stroke that are conserved among kinesins and myosin. We find that kinesin-14 binds to a microtubule by one head during the mechanical cycle, undergoes rate-limiting ADP release, and changes in conformation during ATP binding and hydrolysis to produce force. Notably, kinesin-14 utilizes the same mechanical strategy for force production as other kinesins but couples the changes to a large swing of the stalk, an innovation derived from myosin that is not observed for kinesin-1 or other kinesin motors. Force is produced by rearranging the binding surfaces of the stalk, strand {beta}1, helices [a]4 and [a]6, and the neck mimic, and by twisting and shortening strands of the central {beta}-sheet. These structural changes produce a power stroke - rotation of the helical stalk accompanied by neck mimic docking - during the transition from the nucleotide-free to ATP-bound state, and a reverse stroke after phosphate release that reprimes the motor for the next microtubule binding interaction. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=97 SRC="FIGDIR/small/605428v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1093cdforg.highwire.dtl.DTLVardef@17b6c99org.highwire.dtl.DTLVardef@16b4a5org.highwire.dtl.DTLVardef@add967_HPS_FORMAT_FIGEXP M_FIG C_FIG Kinesin-14 force productionNew transition states and structural movements in a model for motor energy transduction and force production: {beta}-sheet twisting stores free energy in the microtubule-bound nucleotide-free (NF) state. A fluctuating power stroke is produced in the ATP state with neck mimic docking in the ADP{middle dot}Pi state, resembling the kinesin-1 neck linker. This is followed by {beta}-strand-to-loop transitions in the microtubule-bound ADP + free Pi state. Finally, {beta}-sheet refolding drives the recovery stroke for reversion to the ADP state.

biophysics↗

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues

Small molecules that can induce protein degradation by inducing proximity between a desired target and an E3 ligase have the potential to greatly expand the number of proteins that can be manipulated pharmacologically. Current strategies for targeted protein degradation are mostly limited in their target scope to proteins with preexisting ligands. Alternate modalities such as molecular glues, as exemplified by the glutarimide class of ligands for the CUL4CRBN ligase, have been mostly discovered serendipitously. We recently reported a trans-labelling covalent glue mechanism which we named Template-assisted covalent modification, where an electrophile decorated small molecule binder of BRD4 was effectively delivered to a cysteine residue on an E3 ligase DCAF16 as a consequence of a BRD4-DCAF16 protein-protein interaction. Herein, we report our medicinal chemistry efforts to evaluate how various electrophilic modifications to the BRD4 binder, JQ1, affect DCAF16 trans-labeling and subsequent BRD4 degradation efficiency. We discovered a decent correlation between the ability of the electrophilic small molecule to induce ternary complex formation between BRD4 and DCAF16 with its ability to induce BRD4 degradation. Moreover, we show that a more solvent-exposed warhead presentation is optimal for DCAF16 recruitment and subsequent BRD4 degradation. Unlike the sensitivity of CUL4CRBN glue degraders to chemical modifications, the diversity of covalent attachments in this class of BRD4 glue degraders suggests a high tolerance and tunability for the BRD4-DCAF16 interaction. This offers a potential new avenue for a rational design of covalent glue degraders by introducing covalent warheads to known binders.

pharmacology and toxicology↗

Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders

Small molecules that induce protein-protein interactions to exert proximity-driven pharmacology such as targeted protein degradation are a powerful class of therapeutics1-3. Molecular glues are of particular interest given their favorable size and chemical properties and represent the only clinically approved degrader drugs4-6. The discovery and development of molecular glues for novel targets, however, remains challenging. Covalent strategies could in principle facilitate molecular glue discovery by stabilizing the neo-protein interfaces. Here, we present structural and mechanistic studies that define a trans-labeling covalent molecular glue mechanism, which we term "template-assisted covalent modification". We found that a novel series of BRD4 molecular glue degraders act by recruiting the CUL4DCAF16 ligase to the second bromodomain of BRD4 (BRD4BD2). BRD4BD2, in complex with DCAF16, serves as a structural template to facilitate covalent modification of DCAF16, which stabilizes the BRD4-degrader-DCAF16 ternary complex formation and facilitates BRD4 degradation. A 2.2 [A] cryo-electron microscopy structure of the ternary complex demonstrates that DCAF16 and BRD4BD2 have pre-existing structural complementarity which optimally orients the reactive moiety of the degrader for DCAF16Cys58 covalent modification. Systematic mutagenesis of both DCAF16 and BRD4BD2 revealed that the loop conformation around BRD4His437, rather than specific side chains, is critical for stable interaction with DCAF16 and BD2 selectivity. Together our work establishes "template-assisted covalent modification" as a mechanism for covalent molecular glues, which opens a new path to proximity driven pharmacology.

biochemistry↗

Structure and computation-guided design of a mutation-integrated trimeric RBD candidate vaccine with broad neutralization against SARS-CoV-2

The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 is an attractive target for COVID-19 vaccine developments, which naturally exists in a trimeric form. Here, guided by structural and computational analyses, we present a mutation-integrated trimeric form of RBD (mutI tri-RBD) as a broadly protective vaccine candidate, in which three RBDs were individually grafted from three different circulating SARS-CoV-2 strains including the prototype, Beta (B.1.351) and Kappa (B.1.617). The three RBDs were then connected end-to-end and co-assembled to possibly mimic the native trimeric arrangements in the natural S protein trimer. The recombinant expression of the mutI tri-RBD, as well as the homo-tri-RBD where the three RBDs were all truncated from the prototype strain, by mammalian cell exhibited correct folding, strong bio-activities, and high stability. The immunization of both the mutI tri-RBD and homo-tri-RBD plus aluminum adjuvant induced high levels of specific IgG and neutralizing antibodies against the SARS-CoV-2 prototype strain in mice. Notably, regarding to the "immune-escape" Beta (B.1.351) variant, mutI tri-RBD elicited significantly higher neutralizing antibody titers than homo-tri-RBD. Furthermore, due to harboring the immune-resistant mutations as well as the evolutionarily convergent hotspots, the designed mutI tri-RBD also induced strong broadly neutralizing activities against various SARS-CoV-2 variants, especially the variants partially resistant to homo-tri-RBD. Homo-tri-RBD has been approved by the China National Medical Products Administration to enter clinical trial (No. NCT04869592), and the superior broad neutralization performances against SARS-CoV-2 support the mutI tri-RBD as a more promising vaccine candidate for further clinical developments.

immunology↗

Mindfulness meditation alters neural activity underpinning working memory during tactile distraction

Evidence suggests that mindfulness meditation (MM) improves selective attention and reduces distractibility by enhancing top-down neural modulation. Altered P300 and alpha neural activity from MM have been identified and may reflect the neural changes that underpin these improvements. Given the proposed role of alpha activity in supressing processing of task-irrelevant information, it is theorised that altered alpha activity may underlie increased availability of neural resources in meditators. The present study investigated attentional function in meditators using a cross-modal study design, examining the P300 during working memory (WM) and alpha activity during concurrent distracting tactile stimuli. Thirty-three meditators and 27 healthy controls participated in the study. Meditators showed a more frontal distribution of P300 neural activity following WM stimuli (p = 0.005, {eta}{superscript 2} = 0.060) and more modulation of alpha activity at parietal-occipital regions between single (tactile stimulation only) and dual task demands (tactile stimulation plus WM task) (p < 0.001, {eta}{superscript 2} = 0.065). Additionally, meditators performed more accurately than controls (p = 0.038, {eta}{superscript 2} = 0.067). The altered distribution of neural activity concurrent with improved WM performance suggests greater attentional resources dedicated to task related functions such as WM in meditators. Thus, meditation-related neural changes are likely multi-faceted involving both altered distribution and also amplitudes of brain activity, enhancing attentional processes depending on task requirements.

neuroscience↗

RNA editing of CAPS1 regulates synaptic vesicle organization, release and retrieval.

Calcium-dependent activator protein for secretion 1 (CAPS1) facilitates the docking and priming of synaptic and dense core vesicles. A conserved hairpin structure in the CAPS1 pre-mRNA allows an post-transcriptional adenosine-to-inosine RNA editing event to alter a genomically-encoded glutamate to a glycine codon. Functional comparisons of CAPS1 protein isoforms in primary hippocampal neurons show that elevation of edited CAPS1 isoforms facilitates presynaptic vesicle clustering and turnover. Conversely, non-edited CAPS1 isoforms slow evoked release, increase spontaneous fusion, and loosen the clustering of synaptic vesicles. Therefore, CAPS1 editing promotes organization of the vesicle pool in a way that is beneficial for evoked release, while non-edited isoforms promote more lax vesicle organization that widens distribution, attenuates evoked release and eases the control of spontaneous fusion. Overall, RNA editing of CAPS1 is a mechanism to fine tune neurotransmitter release.\n\nIMPACT STATEMENTPost-transcriptional RNA editing of CAPS1 is a mechanism to regulate neurotransmitter release from synaptic vesicles.

biochemistry↗